Theravance Biopharma Inc (TBPH) — Cash Flow Quality Index
Theravance Biopharma Inc (TBPH) has a Cash Flow Quality Index of -0.10x as of December 2025. Operating cash flow of $-6.06 Million is below net income of $61.02 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Theravance Biopharma Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Theravance Biopharma Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Theravance Biopharma Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TBPH total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Theravance Biopharma Inc (2025–2025)
Year-by-year earnings quality comparison for Theravance Biopharma Inc. For live market cap and the full company financial profile, see how much is Theravance Biopharma Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.25x | $238.54 Million | $105.89 Million | — |